Adults with type 2 diabetes who switched from basal insulin therapy to insulin glargine injection experienced similar numbers of hypoglycemia events and decreases in average HbA1c as those who switched to insulin degludec. READ MORE
A recent analysis of real-world data has shown that switching insulin therapies is highly cost-effective for the treatment of type 1 and type 2 diabetes.
A real-life analysis compared multiple antidiabetic medications for increased risk of heart failure hospitalization.
A recent comparative effectiveness study examined the effects of an insulin-sensitizing drug in patients who have suffered a stroke with a high risk for recurrent stroke or myocardial infarction vs those with a low risk.
A patient-driven titration regimen demonstrated better HbA1C control without increasing the risk of hypoglycemia than a physician-driven titration regimen in patients with type 2 diabetes.